WHO GRADE IV GLIOMA
Clinical trials for WHO GRADE IV GLIOMA explained in plain language.
Never miss a new study
Get alerted when new WHO GRADE IV GLIOMA trials appear
Sign up with your email to follow new studies for WHO GRADE IV GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with deadly brain tumors: trial matches treatment to tumor genetics
Disease control Recruiting nowThis study aims to find better treatments for children and young adults newly diagnosed with aggressive brain tumors. Researchers will analyze the genetic makeup of each patient's tumor to match them with a targeted therapy that might work best for their specific cancer. The goal…
Matched conditions: WHO GRADE IV GLIOMA
Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Targeted drug trial offers hope for children with aggressive brain cancer
Disease control Recruiting nowThis study is testing a targeted drug called lorlatinib in children and young adults (ages 1-21) newly diagnosed with aggressive brain tumors (high-grade gliomas) that have specific genetic changes called ALK or ROS1 fusions. The main goals are to see if the drug can control the …
Matched conditions: WHO GRADE IV GLIOMA
Phase: EARLY_PHASE1 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New hope for kids with devastating brain cancer: trial tests Life-Extending drug combos
Disease control Recruiting nowThis study is testing two different drug combinations to see if they can help children and young adults with aggressive brain tumors live longer. The trial is for patients who have just finished radiation therapy. One group receives two drugs (ribociclib and everolimus), while an…
Matched conditions: WHO GRADE IV GLIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC